Thiamine (vitamin B 1 ) deficiency causing Wernicke encephalopathy occurs most frequently in people with compromised absorption (e.g., malnutrition, hyperemesis), increased metabolism (e.g., sepsis, malignancy) or increased carbohydrate intake (e.g., administration of intravenous dextrose). Guidelines from the European Federation of Neurological Societies suggest that Wernicke enceph alopathy is not a rare disorder, but rather a rare diagnosis.
1 The diagnosis is confirmed in 0.4%-2.8% of autopsies, yet may be overlooked in 68% of patients with alcoholism and 94% of patients without alcoholism.
1
Wernicke encephalopathy is a medical emergency with substantial morbidity and mortality A historical case series reported mortality in 17% of patients with acute Wernicke encephalopathy.
2 Of the remainder, 84% given low doses of parenteral thiamine (50-100 mg/d) had irreversible memory impairment consistent with Korsakoff syndrome; only 16% made a full recovery. Wernicke encephalopathy is a clin ical diagnosis. Altered mental state (e.g., confusion, encephalopathy), ocular abnormalities (e.g., nystagmus, ophthalmoplegia) and cerebellar dysfunction (e.g., gait disturbance, ataxia) define this condition. Diagnostic sensitivity can be optimized with the Caine criteria (Box 1).
3

Rapid correction of brain thiamine deficiency is the goal of therapy
Thiamine is an essential vitamin critical to glucose metabolism. Without thiamine, glucose is metabolized through less-efficient anaerobic pathways, which produces lactic acid. Acidosis affecting periventricular structures (i.e., thalami, mammillary bodies, oculomotor nuclei, cerebellar vermis) accounts for the clinical pres entation.
2 Because thiamine crosses the blood-brain barrier via passive and active transport, correction of brain thiamine deficiency can be promoted by maximizing serum thiamine concentrations.
4 Oral absorp tion is unreliable in patients at risk of Wernicke enceph alopathy, which emphasizes the importance of pa ren teral treatment.
1,4
Some thiamine is good for treatment; more may be better There is insufficient evidence from randomized controlled trials to dictate optimal treatment for Wernicke encephalopathy caused by alcohol misuse.
5 Although European guidelines recommend acute treatment with at least 200 mg thiamine intravenously or intramuscularly three times daily for two to three days, 1 the efficacy of higher doses requires further study. Dramatic resolution of neurologic signs signals adequate treatment and confirms the clinical diagnosis of Wernicke encephalopathy.
